Suppr超能文献

Alere i 流感 A&B 检测简介:一种开拓性的即时分子检测试验。

Profile of the Alere i Influenza A & B assay: a pioneering molecular point-of-care test.

机构信息

a Division of Infectious Diseases , Shenzhen Children Hospital , Shenzhen , China.

b Departments of Laboratory Medicine and Internal Medicine , Memorial Sloan-Kettering Cancer Center , New York , NY , USA.

出版信息

Expert Rev Mol Diagn. 2018 May;18(5):403-409. doi: 10.1080/14737159.2018.1466703. Epub 2018 Apr 24.

Abstract

The Alere i Influenza A & B assay incorporates the Nicking Enzyme Amplification Reaction technique on the Alere i instrument to detect and differentiate influenza virus (Flu) A and B nucleic acids in specific specimens. Areas covered: The Alere i Influenza A & B assay was cleared by the US Food and Drug Administration for use with nasal swabs (NS) and nasopharyngeal swabs, either directly or in viral transport medium. Notably, direct use on NS was the first ever CLIA-waived nucleic acid-based test. Previously published evaluations have reported sensitivities and specificities of 55.2-100% and 62.5-100% for Flu A and 45.2-100% and 53.6-100% for Flu B, respectively. Expert commentary: The Alere i Influenza A & B assay provides a rapid and simple platform for detection and differentiation of Flu A and B. Efforts are expected to further improve sensitivity and user-friendliness for effective and widespread use in the true point-of-care setting.

摘要

Alere i 流感 A&B 检测试剂盒采用了 Nicking 酶扩增反应技术,在 Alere i 仪器上检测并区分特定样本中的流感病毒(Flu)A 和 B 核酸。

涵盖领域

美国食品和药物管理局已批准 Alere i 流感 A&B 检测试剂盒用于鼻腔拭子(NS)和鼻咽拭子,可直接使用或在病毒运输介质中使用。值得注意的是,直接使用 NS 是首个获得 CLIA 豁免的基于核酸的检测。先前发表的评估报告分别报告了 Flu A 的灵敏度和特异性为 55.2-100%和 62.5-100%,以及 Flu B 的灵敏度和特异性为 45.2-100%和 53.6-100%。

专家评论

Alere i 流感 A&B 检测试剂盒为检测和区分 Flu A 和 B 提供了一个快速简单的平台。预计将进一步提高灵敏度和用户友好性,以便在真正的即时护理环境中有效且广泛地使用。

相似文献

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验